165 related articles for article (PubMed ID: 23892484)
1. Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract.
Asvadi NH; Dang NT; Davis-Poynter N; Coombes AG
J Mater Sci Mater Med; 2013 Dec; 24(12):2719-27. PubMed ID: 23892484
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV.
Dang NT; Sivakumaran H; Harrich D; Coombes AG
J Pharm Sci; 2013 Oct; 102(10):3725-35. PubMed ID: 23904196
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
Moss JA; Malone AM; Smith TJ; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Vincent KL; Motamedi M; Friend DR; Clark MR; Baum MM
Antimicrob Agents Chemother; 2012 Feb; 56(2):875-82. PubMed ID: 22123689
[TBL] [Abstract][Full Text] [Related]
4. Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis.
Fernando HV; Chan LL; Dang N; Santhanes D; Banneheke H; Nalliah S; Coombes AGA
Pharm Dev Technol; 2019 Mar; 24(3):348-356. PubMed ID: 29799300
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Polycaprolactone Matrices for Intravaginal Delivery of Doxycycline.
Pathak M; Coombes AGA; Turner MS; Palmer C; Wang D; Steadman KJ
J Pharm Sci; 2015 Dec; 104(12):4217-4222. PubMed ID: 26398713
[TBL] [Abstract][Full Text] [Related]
6. Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents.
Dang NT; Turner MS; Coombes AG
J Biomater Appl; 2013 Jul; 28(1):74-83. PubMed ID: 22684517
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of polycaprolactone matrices for sustained vaginal delivery of nevirapine in the prevention of heterosexual HIV transmission.
Dang N; Sivakumaran H; Harrich D; Shaw PN; Coombes AGA
J Pharm Sci; 2014 Jul; 103(7):2107-2115. PubMed ID: 24867411
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis.
Pathak M; Turner M; Palmer C; Coombes AG
J Biomater Appl; 2014 Sep; 29(3):354-63. PubMed ID: 24682036
[TBL] [Abstract][Full Text] [Related]
9. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.
Dang NT; Sivakumaran H; Harrich D; Shaw PN; Davis-Poynter N; Coombes AG
Eur J Pharm Biopharm; 2014 Oct; 88(2):406-14. PubMed ID: 24887313
[TBL] [Abstract][Full Text] [Related]
10. Sustained Simultaneous Delivery of Metronidazole and Doxycycline From Polycaprolactone Matrices Designed for Intravaginal Treatment of Pelvic Inflammatory Disease.
Pathak M; Coombes AGA; Ryu B; Cabot PJ; Turner MS; Palmer C; Wang D; Steadman KJ
J Pharm Sci; 2018 Mar; 107(3):863-869. PubMed ID: 29100864
[TBL] [Abstract][Full Text] [Related]
11. An intravaginal ring for the simultaneous delivery of multiple drugs.
Baum MM; Butkyavichene I; Gilman J; Kennedy S; Kopin E; Malone AM; Nguyen C; Smith TJ; Friend DR; Clark MR; Moss JA
J Pharm Sci; 2012 Aug; 101(8):2833-43. PubMed ID: 22619076
[TBL] [Abstract][Full Text] [Related]
12. Carrageenan-Based Acyclovir Mucoadhesive Vaginal Tablets for Prevention of Genital Herpes.
Pacheco-Quito EM; Ruiz-Caro R; Rubio J; Tamayo A; Veiga MD
Mar Drugs; 2020 May; 18(5):. PubMed ID: 32403219
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.
Ursell LK; Gunawardana M; Chang S; Mullen M; Moss JA; Herold BC; Keller MJ; McDonald D; González A; Knight R; Baum MM
Antiviral Res; 2014 Feb; 102():87-94. PubMed ID: 24361269
[TBL] [Abstract][Full Text] [Related]
14. Controlled release and antiviral activity of acyclovir-loaded PLA/PEG nanofibers produced by solution blow spinning.
Ferreira KN; Oliveira RR; Castellano LRC; Bonan PRF; Carvalho OV; Pena L; Souza JR; Oliveira JE; Medeiros ES
Biomater Adv; 2022 May; 136():212785. PubMed ID: 35929318
[TBL] [Abstract][Full Text] [Related]
15. Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.
Keller MJ; Malone AM; Carpenter CA; Lo Y; Huang M; Corey L; Willis R; Nguyen C; Kennedy S; Gunawardana M; Guerrero D; Moss JA; Baum MM; Smith TJ; Herold BC
J Antimicrob Chemother; 2012 Aug; 67(8):2005-12. PubMed ID: 22556381
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.
Aniagyei SE; Sims LB; Malik DA; Tyo KM; Curry KC; Kim W; Hodge DA; Duan J; Steinbach-Rankins JM
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():238-251. PubMed ID: 28024582
[TBL] [Abstract][Full Text] [Related]
17. Delivery of the antibiotic gentamicin sulphate from precipitation cast matrices of polycaprolactone.
Chang HI; Perrie Y; Coombes AGA
J Control Release; 2006 Jan; 110(2):414-421. PubMed ID: 16325955
[TBL] [Abstract][Full Text] [Related]
18. Polymeric micelles for acyclovir drug delivery.
Sawdon AJ; Peng CA
Colloids Surf B Biointerfaces; 2014 Oct; 122():738-745. PubMed ID: 25193154
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
[TBL] [Abstract][Full Text] [Related]
20. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
